Last reviewed · How we verify
NCT06676228
Fear of Cancer Recurrence Therapy (FORT): Turkish Cultural Adaptation and Implementation Project
NA trial testing Fear of cancer recurrence therapy (FORT) in Self Efficacy in 100 participants. Completed in 26 September 2025.
26 September 2025
Quick facts
| Lead sponsor | Maltepe University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 October 2024 |
| Primary completion | 26 September 2025 |
| Estimated completion | 26 September 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Fear of cancer recurrence therapy (FORT)
- cognitive-behavioural therapy (CBT) group
Conditions studied
- Self Efficacy — all drugs for Self Efficacy →
- Anxiety — all drugs for Anxiety →
- Depression Not Otherwise Specified — all drugs for Depression Not Otherwise Specified →
- Fear of Cancer Recurrence — all drugs for Fear of Cancer Recurrence →
Sponsor
Maltepe University
Who can join
Adults 18 to 65, female only, with Self Efficacy or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research consists of two phases. The aim of the first study is to adapt the group work module of Fear of Cancer Recurrence (FCR) for FCR in survivors of breast and ovarian cancer patients to the Turkish culture. For cultural adaptation, a process consisting of four stages is planned to be followed based on the World Health Organisation (WHO) and ecological validity model: 1) literature review; 2) translation of the intervention manual from English to Turkish and evaluation of the translation by experts; 3) cognitive interviews with ovarian and breast cancer patients and experts working in the field of psychooncology about the sections of the translated manual; and 4) an adaptation workshop where data from the previous stages were collected and analysed. The aim of the second study, 6-week, 120-minute FCR (n= 68) or CBT intervention (n= 68) group sessions with participants from ovarian and breast cancer patients. They will be completing questionnaires at baseline (T0), post-treatment right after treatment ends (T1), 3 months (T2), and 6 months (T3) post-treatment. A generalized linear model will be used for the analysis of collected data, incorporating customized analyses such as ANCOVA for repeated measures and analysis of variance for repeated measures. The primary outcome will be compared to the Fear of Cancer Recurrence Inventory (FCRI) total score and group differences in secondary outcomes. With this project, it is aimed to bring the group intervention module for FCR, which is a common problem in surviving cancer patients that will greatly contribute to the psycho-oncology practice in Turkiye. In addition, it is thought that this project is important both because there is no study on cancer survivors and FCR in this context and cultural adaptation studies are crucially limited in Turkey.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Preliminary Outcomes of a Culturally Adapted Fear of Recurrence Therapy (FORT) for Turkish Breast Cancer Survivors: A Randomized Controlled Trial.
Eyrenci A, Ertuna L, Bahçivan O. · · 2025 · PMID 41318944 · DOI 10.1002/pon.70345
Verify or expand the search:
- PubMed search for NCT06676228
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Self Efficacy
Currently open trials in the same condition.
- NCT07464548 — Effects of Stoma Education on Patients · NA · recruiting
- NCT07433608 — Video Game Intervention In Older Adults · NA · recruiting
- NCT07221422 — The PREGNANT (Pregnant Resident Empowerment, GuidaNce, and Advocacy iN Training) Coaching Project · NA · recruiting
- NCT07262372 — Supervision in Substance Use Disorder Treatment Programs · NA · recruiting
- NCT06842576 — Health Care Transition Readiness Short-Form Video Intervention · NA · recruiting
Other Maltepe University trials
Trials by the same sponsor.
- NCT06209060 — Hammock Position and Nesting in the Neonatal Intensive Care Unit · NA · recruiting
- NCT06988748 — Diet Education and Postoperative Outcomes in Pediatric Adenotonsillectomy · NA · not yet recruiting
- NCT07272369 — Video vs. Game-Based Teaching of Intramuscular Injection · NA · completed
- NCT06626815 — The Effect of Different Kangaroo Positions on Newborns During Heel Lancing · NA · not yet recruiting
- NCT06999759 — Concealment of Chemotherapy Drug Serum With a Picture Box Effect on Anxiety, Nausea and Vomiting in Children · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06676228 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Maltepe University
- Last refreshed: 2 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06676228.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing